Clinical Trials

BCC021 - Phase I/II Study of Silmitasertib (CX-4945) in Combination With Chemotherapy in Children and Young Adults With Relapsed Refractory Solid Tumors

Link : https://www.clinicaltrials.gov/ct2/show/NCT06541262
Status : span class="RECRUITINGgreen">RECRUITING
Population : up to 30 Years with recurrent Ewing's Sarcoma, Osteosarcoma, Rhabdomyosarcoma, Liposarcoma
Description : Silmitasertib (CX-4945) in Combination With Chemotherapy
PI : M. Marzouki
Centers Opened : CHU Ste-Justine
Phase : I/II
IIST/Pharma : IIST